• OPEN AN ACCOUNT
Indian Indices
Sensex
74,781.76 -120.83
( -0.16%)
Global Indices
Nasdaq
52,596.82 511.72
(0.98%)
Dow Jones
7,678.62 65.92
(0.87%)
Hang Seng
63,979.83 -1,291.12
(-1.98%)
Nikkei 225
10,650.44 41.52
(0.39%)
Forex
USD-INR
95.45 0.39
(0.41%)
EUR-INR
110.95 0.35
(0.32%)
GBP-INR
129.16 0.36
(0.28%)
JPY-INR
0.62 0.00
(0.09%)

EQUITY - MARKET SCREENER

Rubicon Research Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
544578
INE506V01022
81.7556682
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
RUBICON
129.28
30430.56
EPS(TTM)
Face Value()
Div & Yield %
14.22
1
0.08
 

emco ltd
Incon Engineers reports standalone net loss of Rs 0.11 crore in the March 2026 quarter
May 30,2026
Net Loss of Incon Engineers reported to Rs 0.11 crore in the quarter ended March 2026 as against net loss of Rs 0.09 crore during the previous quarter ended March 2025. Sales reported to Rs 0.07 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.43 crore in the year ended March 2026 as against net loss of Rs 0.41 crore during the previous year ended March 2025. Sales rose 28.57% to Rs 0.27 crore in the year ended March 2026 as against Rs 0.21 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.070 0 0.270.21 29
OPM %-185.710 --181.48-228.57 -
PBDT-0.11-0.09 -22 -0.42-0.39 -8
PBT-0.11-0.09 -22 -0.43-0.41 -5
NP-0.11-0.09 -22 -0.43-0.41 -5